Formulation Development

Formulation Development

Services

Information

mimsys® Biomaterial-based formulation development platform Product platform providing de novo customised New Chemical Entities (NCEs) addressing ample opportunities along the manufacturing cycle of advanced therapies: - Cell expansion - Cell storage - Formulation of end-product
STEMMATTERS
30
Stemmatters is an end-to-end integrated Contract Development and Manufacturing Organization (CDMO), providing support spanning from exploratory R&D to GMP manufacturing and clinical batch release. Stemmatters core expertise is on cell-based advanced therapies and blood-derived biologics – both investigational medicinal products and ancillary/raw materials to support cell manufacturing. Stemmatters' innovative biomaterial product platform further enhances its offerings, allowing for the formulation of combination products targeting multiple indications. Based in Portugal, Stemmatters' dedicated team of professionals takes a case-by-case approach, providing detailed, customized and cost-effective CMC solutions.

Log in

See all the content and easy-to-use features by logging in or registering!